Patents Examined by Lisa J. Hobbs
  • Patent number: 8809501
    Abstract: The invention relates to materials and methods of conjugating a water soluble polymer to an oxidized carbohydrate moiety of a therapeutic protein comprising contacting the oxidized carbohydrate moiety with an activated water soluble polymer under conditions that allow conjugation. More specifically, the present invention relates to the aforementioned materials and methods wherein the water soluble polymer contains an active aminooxy group and wherein an oxime or hydrazone linkage is formed between the oxidized carbohydrate moiety and the active aminooxy group on the water soluble polymer, and wherein the conjugation is carried out in the presence of a nucleophilic catalyst.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: August 19, 2014
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Juergen Siekmann, Stefan Haider, Hanspeter Rottensteiner, Peter Turecek
  • Patent number: 8802408
    Abstract: The present invention relates to a process for preparing a nutritional, therapeutic or organoleptic product by growing non-recombinant yeast under aerobic conditions, in a medium that includes crude glycerol, as one possible carbon source to produce a yeast product. The yeast product can be processed to obtain such nutritional, therapeutic or organoleptic products as yeast paste, yeast metabolites, carbohydrates, proteins, functional proteins, nucleotides, yeast autolysates, yeast extract, yeast cell walls, beta-glucans, mannans or a product derived from a mineralized yeast product.
    Type: Grant
    Filed: January 16, 2009
    Date of Patent: August 12, 2014
    Assignee: Bio Processing Australia Pty Ltd.
    Inventors: Robin Fieldhouse, Donald Finlay MacLennan, David Graham MacLennan, Mary Elizabeth MacLennan
  • Patent number: 8765451
    Abstract: The present invention provides a method of treating an off-gas stream (80) comprising NH3 and H2S to provide a sulphate stream (910), the method comprising the steps of: (i) providing a first off-gas stream (80) comprising NH3, H2S, CO2 and optionally one or more of HCN, COS and CS2; (ii) passing the first off-gas stream (80) to an incinerator (300) to oxidize NH3, H2S, and optionally one or more of HCN, COS and CS2 to provide a second off-gas stream (310) comprising N2, H2O, SO2 and CO2; (iii) scrubbing the second off-gas stream (310) with a first aqueous alkaline stream (380, 876a) in a caustic scrubber (350) to separate SO2 and a part of the CO2 from the second off-gas stream to provide a spent caustic stream (360) comprising carbonate and one or both of sulphite and bisulphite and a caustic scrubber off-gas stream (370) comprising N2 and CO2; and (iv) passing the spent caustic stream (360) to an aerator (900) comprising sulphur-oxidizing bacteria in the presence of oxygen to biologically oxidize sulphite
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: July 1, 2014
    Assignee: Shell Oil Company
    Inventor: Sandra Schreuder
  • Patent number: 8753609
    Abstract: A standardized, edible food containing a label for use in the measurement of gastric emptying by the quantification of marker excreted in the breath of the patient and methods of making the same using fluid bed granulation processing.
    Type: Grant
    Filed: June 10, 2009
    Date of Patent: June 17, 2014
    Assignee: Advanced Breathe Diagnostics, LLC
    Inventors: Kerry C. Bush, Stanley J. Konopka, Ronald W. Sanda
  • Patent number: 8741326
    Abstract: A bioscaffolding can be formed from a mixture of gel components of different gelation systems. For example, a bioscaffolding can be formed by mixing at least two different components of at least two different two-component gelation systems to form a first mixture and by mixing at least two different components (other than the components that make up the first mixture) of the at least two different two-component gelation systems to form a second mixture. A treatment agent, such as a cell type or a growth factor, can be added to either the first mixture or the second mixture. In some embodiments, the treatment agent is not added to either mixture. The first mixture can be co-injected with the second mixture to form a bioscaffolding in an infarct region for treatment thereof.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: June 3, 2014
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Gene Michal, Shubhayu Basu
  • Patent number: 8741591
    Abstract: The present invention encompasses a glucose indicator protein, a biosensor comprising one or more glucose indicator proteins, and methods of use thereof.
    Type: Grant
    Filed: October 12, 2010
    Date of Patent: June 3, 2014
    Assignee: The Research Foundation for The State University of New York
    Inventors: Kaiming Ye, Sha Jin
  • Patent number: 8741589
    Abstract: Provided are methods for determining concurrently with a simple, minimally invasive test, the adequacy of pancreatic beta-cell compensation and/or the presence of tissue insulin resistance in a subject human or an experimental animal. The methods allow for the determination of a subject's or experimental animal's susceptibility to developing type 2 diabetes mellitus (DM2) or to progression to more advanced forms of DM2.
    Type: Grant
    Filed: June 12, 2006
    Date of Patent: June 3, 2014
    Assignee: The Regents of the University of California
    Inventor: Marc K. Hellerstein
  • Patent number: 8735148
    Abstract: Disclosed herein are activated NK cells that exhibit durable and prolonged activity in the absence of the activating agent and retain their activated state after preservation. Methods of administrating the NK cells to a patient do not require co-administration of the activating agent, and thus, pharmaceutical compositions comprising the NK cells may remain substantially free of the activating agent.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: May 27, 2014
    Assignee: UCL Business PLC
    Inventor: Mark Lowdell
  • Patent number: 8735083
    Abstract: The present invention deals with reagents and compositions capable of effectively inhibiting peroxidase activity. According to the invention, peroxidase enzymatic activity is blocked with an acidic aqueous solution of a protein denaturing agent. preferred protein denaturing agents are detergents and chaotropic substances.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: May 27, 2014
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Manfred Watzele, Bernd Buchberger, Claudia Kirr
  • Patent number: 8728461
    Abstract: A novel lactic acid bacterium strain is found, which has a high IgA production-inducing ability and a high immunostimulating activity, and belongs to the genus Enterococcus. Thus, provided is an excellent lactic acid bacterium preparation for foods or feeds, which has a high enteric colonization rate. Specifically disclosed are: a novel lactic acid bacterium Enterococcus faecium NHRD IHARA (FERM BP-11090) which has a high IgA production-inducing ability and a high immunostimulating activity; and a lactic acid bacterium preparation for enhancing the production of immunoglobulin A, which comprises a culture of the bacterium strain, an extract of the bacterium strain, or a product of any treatment of cells of the bacterium strain.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: May 20, 2014
    Assignee: Nippon Meat Packers, Inc.
    Inventors: Yasuhiro Ihara, Hiroshi Murakami, Yoichi Takahagi
  • Patent number: 8728758
    Abstract: A method of measuring a metabolic activity (MA) of a cell is provided. The method comprising independently measuring in an extracellular environment of the cell, time-dependent acidification profiles due to secretion of: (i) non-volatile soluble metabolic products; (ii) non-volatile soluble metabolic products and volatile soluble metabolic products; and (iii) volatile soluble metabolic products; wherein at least one of the time dependent acidification profiles is indicative of the metabolic activity of the cell. Also provided are clinical methods which make use of the assay.
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: May 20, 2014
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Reuven Tirosh, Fernando Patolsky, Hagit Peretz-Soroka
  • Patent number: 8722389
    Abstract: A system and method for culturing algae are presented. The system and method utilize a fog of growth medium that is delivered to an algal mat generator along with a stream of CO2 to promote growth of algal cells contained in the generator.
    Type: Grant
    Filed: April 19, 2011
    Date of Patent: May 13, 2014
    Assignee: U.S. Department of Energy
    Inventors: Keshav C. Das, Benjamin R. Cannon, Ashish Bhatnagar, Senthil Chinnasamy
  • Patent number: 8722376
    Abstract: According to one embodiment, the present invention relates to luciferase derived from Malaysian Luciola firefly, the luciferase having a maximum luminescent wavelength of 580 nm at pH 8, or the luciferase indicating 23.3 times or more of luminescent intensity in comparison to that of Rhodamine 6G.
    Type: Grant
    Filed: August 20, 2012
    Date of Patent: May 13, 2014
    Assignees: Olympus Corporation, Nimura Genetic Solutions Co., Ltd., Perak State Development Corporation
    Inventors: Katsunori Ogo, Ryutaro Akiyoshi, Hirobumi Suzuki
  • Patent number: 8709761
    Abstract: Saccharification of polysaccharides of plants is provided, where release of fermentable sugars from cellulose is obtained by adding plant tissue composition. Production of glucose is obtained without the need to add additional ?-glucosidase. Adding plant tissue composition to a process using a cellulose degrading composition to degrade cellulose results in an increase in the production of fermentable sugars compared to a process in which plant tissue composition is not added. Using plant tissue composition in a process using a cellulose degrading enzyme composition to degrade cellulose results in decrease in the amount of cellulose degrading enzyme composition or exogenously applied cellulase required to produce fermentable sugars.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: April 29, 2014
    Assignee: Applied Biotechnology Institute, Inc.
    Inventors: John Howard, Gina Fake
  • Patent number: 8709742
    Abstract: Saccharification of polysaccharides of plants is provided, where release of fermentable sugars from cellulose is obtained by adding plant tissue composition. Production of glucose is obtained without the need to add additional ?-glucosidase. Adding plant tissue composition to a process using a cellulose degrading composition to degrade cellulose results in an increase in the production of fermentable sugars compared to a process in which plant tissue composition is not added. Using plant tissue composition in a process using a cellulose degrading enzyme composition to degrade cellulose results in decrease in the amount of cellulose degrading enzyme composition or exogenously applied cellulase required to produce fermentable sugars.
    Type: Grant
    Filed: October 9, 2010
    Date of Patent: April 29, 2014
    Assignee: Applied Biotechnology Institute, Inc.
    Inventors: John Howard, Gina Fake
  • Patent number: 8679832
    Abstract: Methods and compositions are provided for detecting molecular translocations, particularly protein translocations within and between sub-cellular compartments, using at least two components that exhibit a localization-dependent difference in complementation activity. In particular, alpha-complementing ?-galactosidase fragments are provided. These ?-galactosidase reporter fragments display significantly enhanced enzymatic activity when one fragment is localized in a membrane. Methods for carrying out no-wash ELISA assays based on the reporter component system are also provided.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: March 25, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Helen M. Blau, Thomas S. Wehrman
  • Patent number: 8673588
    Abstract: The present invention relates to a composition and method for handling tissue samples for analysis. In particular the present invention relates to a composition and method for orientating tissue for histological and/or pathological laboratory analysis.
    Type: Grant
    Filed: September 5, 2007
    Date of Patent: March 18, 2014
    Assignee: Leica Biosystems Melbourne Pty Ltd
    Inventors: Jason Douglas Watling, Nick Hausler, Costa Conn
  • Patent number: 8642309
    Abstract: The invention relates to an amphiphilic polymer comprising at least 75% of amphiphilic monomers of formula (I), the average molar mass of the polymer being between 800 and 100 000, and also water-soluble complexes between the polymer according to the invention and a hydrophobic or amphiphilic compound, in particular a membrane protein, a concentrated aqueous solution of one or more such complex(es), a product comprising one or more such complex(es) attached to a substrate by means of the polymer according to the invention, and various uses of these products.
    Type: Grant
    Filed: November 16, 2010
    Date of Patent: February 4, 2014
    Assignees: Centre National de la Recherche Scientifique (CNRS), University d'Avignon et des Pays de Vaucluse
    Inventors: Bernard Pucci, Fabrice Giusti, Paola Bazzacco, Jean-Luc Popot, Sharma Kshatrapati Shivaji, Gregory Durand
  • Patent number: 8642273
    Abstract: Disclosed are methods for the preparation and use of labeled AChE and labeled AChE inhibitory conjugate compositions for detecting accumulation of toxic materials such as organophosphates, insecticides, and other nerve agents. Also disclosed are methods for the use of labeled AChE and labeled AChE inhibitory conjugate compositions in a variety of areas, including the detecting of toxic materials in biological samples, in the area of food and water analysis, in environmental monitoring, and in industrial settings.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: February 4, 2014
    Assignee: The Regents of the University of California
    Inventors: Palmer Taylor, Zoran Radic, Jianxin Shi, Aileen Boyd
  • Patent number: 8642737
    Abstract: The invention relates to materials and methods of conjugating a water soluble polymer to an oxidized carbohydrate moiety of a therapeutic protein comprising contacting the oxidized carbohydrate moiety with an activated water soluble polymer under conditions that allow conjugation. More specifically, the present invention relates to the aforementioned materials and methods wherein the water soluble polymer contains an active aminooxy group and wherein an oxime or hydrazone linkage is formed between the oxidized carbohydrate moiety and the active aminooxy group on the water soluble polymer, and wherein the conjugation is carried out in the presence of a nucleophilic catalyst.
    Type: Grant
    Filed: July 29, 2011
    Date of Patent: February 4, 2014
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Juergen Siekmann, Stefan Haider, Hanspeter Rottensteiner, Andreas Ivens, Peter Turecek, Oliver Zoechling